Clinical trial
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
NCT00433628 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00433628 |
|---|---|
| Title | Accuracy of Hemoglobin A1C to Predict Glycemia in HIV |
| Official title | Accuracy of Hemoglobin A1C to Predict Glycemia in HIV |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV, Diabetes, Hyperglycemia |
| Enrollment | 175 |
| Start date | Feb 7, 2007 |
| Primary completion | Nov 12, 2008 |
| First posted | Feb 12, 2007 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: